跳到正文
MSK Department of Medicine· @MSK_DeptOfMed · X·· 2026-04-21评分60
正文 · 原文

Kicking off today's poster session at #AACR26: Dr. Brian Chernak will share phase I results on ruxolitinib + the CDK4/6 inhibitor abemaciclib in previously treated #myelofibrosis.
@MSKCancerCenter

@AACR

@BrianChernak

9 a.m.–12 p.m. PDT

https://
bit.ly/4dRLPK1

热度 9 · 5 赞 · 0 回复 · 4 转发

会议摘要
CT262按 药名 abemaciclib 对上
Elacestrant (Ela) in combination with everolimus (Eve) or abemaciclib (Abema) in patients with ER+/HER2- locally advanced or metastatic breast cancer mBC: phase 2 results from ELEVATE, an open-label, umbrella study

Hope S. Rugo, Sara M. Tolaney, Nancy Chan, Giuliano Borges, Rinat Yerushalmi, Marina N. Sharifi, Wassim McHayleh, Thaddeus Beck, Neelima Vidula, Erika Hamilton, Kristine J. Rinn, Joyce O’Shaughnessy, Giuseppe Curigliano, Javier Cortés, Paula Muñoz Romero, Giulia Tonini, Alessandro Paoli, Monica Binaschi, Li Cheng, Jennifer A. Crozier, Tomer Wasserman, Virginia Kaklamani

读摘要原文 →

来源:MSK Department of Medicine · x.com

CBACBA Frontier Insights (CFI)美国华人生物医药科技协会(CBA)www.cba-usa.org